| Followers | 152 |
| Posts | 4903 |
| Boards Moderated | 0 |
| Alias Born | 11/03/2016 |
Wednesday, October 27, 2021 1:54:35 PM
I got frustrated at the bs and spoke out. I spent about four hours back in January February researching all the way back through attorneys llc’s shell corps, failed SEC applications, toxicity in Europe etc.
it’s all there.
Sometimes a continuously falling share price is manipulated but sometimes ( most) it just reflects reality.
Best of luck. No ill will. I’m gone but if reality continues to head south.... at some point you have to acknowledge the truth.
it’s all there.
Sometimes a continuously falling share price is manipulated but sometimes ( most) it just reflects reality.
Best of luck. No ill will. I’m gone but if reality continues to head south.... at some point you have to acknowledge the truth.
Recent SBFM News
- Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing • ACCESS Newswire • 05/28/2026 01:00:00 PM
- Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin • ACCESS Newswire • 05/21/2026 11:00:00 AM
- Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering • ACCESS Newswire • 05/19/2026 04:05:00 PM
- Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering • ACCESS Newswire • 05/18/2026 04:15:00 PM
- Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year • ACCESS Newswire • 04/06/2026 12:30:00 PM
- Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea • ACCESS Newswire • 10/28/2025 11:45:00 AM
- Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline • ACCESS Newswire • 10/20/2025 11:45:00 AM
- Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin • ACCESS Newswire • 10/16/2025 11:45:00 AM
- Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience • ACCESS Newswire • 10/14/2025 11:00:00 AM
- Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections • ACCESS Newswire • 10/09/2025 12:00:00 PM
